Novozyme Emissions Target Approved by SBTi - Diversified Communications

Commercial, GHG Emissions  -  November 16, 2022

Novozyme Emissions Target Approved by SBTi

Novozymes announced its net-zero target was validated by the Science Based Targets initiative.

The enzyme and microbial technologies provider renewed its climate targets and by 2030 will reduce its absolute CO2 emissions across its operation by 75% and reduce its absolute CO2 emissions from its supply chain by 35%. By 2050, Novozymes will reach net-zero. 

The company also commits to increasing annual sourcing of renewable electricity from 37% in 2018
to 100% by 2025. Novozymes further commits to reducing absolute scope 3 GHG emissions from purchased goods
and services, fuel and energy-related activities, upstream transportation and distribution, waste generated in
operations and business travel 35% by 2030 from a 2018 base year.

“Novozymes is dedicated to building a net-zero future and accelerating decarbonization across our value chain. As a global leader, we embrace our leadership responsibility by setting the tone and leading by example together with less than 100 companies – across sectors – in the world, who has now obtained validation of their long-term net-zero targets for scope 1, 2, and 3 by SBTi,” says Ester Baiget, President & CEO, in a statement. “We have a long history of bold sustainability commitments, and we are ready to take our commitments to the next level. We will reach for net-zero by 2050 and we accelerate our 2025 renewable electricity target.” 

 

 

Tags: Novozyme

« Back to Energy Management

  • LinkedIn
  • Subscribe

Smart Energy Decisions Content Partners